Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation.

Hill Rs(Fred Hutch Cancer Center), Jack W. Singer(NorthShore University HealthSystem), Simona Sica(San Antonio College), Patrizio Mazza(Ospedale SS. Annunziata), D. B. Amos(Florida College), CD Buckner(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), R. J. Berenson(Fred Hutch Cancer Center), Still Bj, Appelbaum Fr, Patrick Martin
PubMed
January 1, 1989
Cited by 23

Related Papers

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Effect of HLA Compatibility on Engraftment of Bone Marrow Transplants in Patients with Leukemia or Lymphoma
|New England Journal of Medicine|1989|687
Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission
|New England Journal of Medicine|1979|646
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.
|PubMed|1996|645